Insights from MRI Radiomics

Effrosyni I. Styliara,Loukas G. Astrakas,George Alexiou,Vasileios G. Xydis,Anastasia Zikou,Georgios Kafritsas,Spyridon Voulgaris,Maria I. Argyropoulou
DOI: https://doi.org/10.3390/curroncol31040165
2024-04-14
Current Oncology
Abstract:Background: Extracting multiregional radiomic features from multiparametric MRI for predicting pretreatment survival in isocitrate dehydrogenase (IDH) wild-type glioblastoma (GBM) patients is a promising approach. Methods: MRI data from 49 IDH wild-type glioblastoma patients pre-treatment were utilized. Diffusion and perfusion maps were generated, and tumor subregions segmented. Radiomic features were extracted for each tissue type and map. Feature selection on 1862 radiomic features identified 25 significant features. The Cox proportional-hazards model with LASSO regularization was used to perform survival analysis. Internal and external validation used a 38-patient training cohort and an 11-patient validation cohort. Statistical significance was set at p 0.65) at all time points. Conclusions: Radiomics analysis, utilizing segmented perfusion and diffusion maps, provide predictive indicators of survival in IDH wild-type glioblastoma patients, revealing associations with microstructural and vascular heterogeneity in the tumor.
oncology
What problem does this paper attempt to address?